|
ZNF664 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.539770E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.967000E-04 |
| Normal-vs-Stage2 |
3.388100E-02 |
| Normal-vs-Stage3 |
2.131200E-01 |
| Normal-vs-Stage4 |
8.414300E-02 |
| Stage1-vs-Stage2 |
8.719400E-01 |
| Stage1-vs-Stage3 |
4.708800E-01 |
| Stage1-vs-Stage4 |
9.132800E-01 |
| Stage2-vs-Stage3 |
4.733400E-01 |
| Stage2-vs-Stage4 |
9.907200E-01 |
| Stage3-vs-Stage4 |
5.687400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.951500E-04 |
| Normal-vs-AfricanAmerican |
5.374000E-01 |
| Normal-vs-Asian |
3.400900E-03 |
| Caucasian-vs-AfricanAmerican |
7.160000E-02 |
| Caucasian-vs-Asian |
5.664200E-01 |
| AfricanAmerican-vs-Asian |
2.312200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.047400E-04 |
| Normal-vs-Female |
2.637400E-01 |
| Male-vs-Female |
1.013440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.302320E-02 |
| Normal-vs-Extreme_Weight |
1.845550E-04 |
| Normal-vs-Obese |
8.090200E-02 |
| Normal-vs-Extreme_Obese |
4.657600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.610000E-01 |
| Normal_Weight-vs-Obese |
3.565800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.917400E-01 |
| Extreme_Weight-vs-Obese |
7.132100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.221600E-01 |
| Obese-vs-Extreme_Obese |
8.192400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.808000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.902400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.441380E-03 |
| Normal-vs-Age(81-100Yrs) |
1.082090E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.539400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.757630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.900500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.986630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.809900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.234100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.796000E-03 |
| Normal-VS-Type2 PRCC |
1.201910E-04 |
| Normal-VS-KIRP CIMP |
7.159800E-01 |
| Normal-VS-Unclassified PRCC |
6.548200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.679700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.341200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.896200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.580220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.506000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.934600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45739999999994E-05 |
| Normal-vs-N1 |
9.082800E-01 |
| Normal-vs-N2 |
3.705900E-02 |
| N0-vs-N1 |
3.379900E-02 |
| N0-vs-N2 |
8.590600E-01 |
| N1-vs-N2 |
4.048400E-01 |
|
|
